Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corrado Pelaia

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Vaccines|March 30, 2023
Special Issue on 'Asthma and Allergic Inflammation'Corrado Pelaia
ERJ Open Research|September 25, 2024
Interleukin 33: a suitable target for biological therapies of COPD?Corrado Pelaia
Medicina (Kaunas, Lithuania)|May 4, 2026
Chronic Respiratory Diseases: The Stories You Don't Want to MissMarcin Kurowski, Laura Malinauskienė, Corrado Pelaia
American Journal of Respiratory and Critical Care Medicine|December 8, 2023
Do Comorbidities Influence the Response to Biologics in Severe Asthma?Corrado Pelaia, Girolamo Pelaia, William Busse
Expert Opinion on Pharmacotherapy|April 8, 2017
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapyCarolina Vitale, Angelantonio Maglio, Corrado Pelaia, et al.
Respiratory Medicine|July 9, 2022
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicVincenzo Patella, Corrado Pelaia, Roberta Zunno, et al.
Drug Design, Development and Therapy|April 3, 2018
Benralizumab in the treatment of severe asthma: design, development and potential place in therapyCorrado Pelaia, Alessandro Vatrella, Andrea Bruni, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2023
Tezepelumab for asthmaSanti Nolasco, Corrado Pelaia, Giulia Scioscia, et al.
Expert Review of Respiratory Medicine|February 21, 2020
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectivesCorrado Pelaia, Alessandro Vatrella, Angela Sciacqua, et al.
Biomedicines|January 25, 2025
Connections and Unmet Needs: Severe Asthma Biologics and OsteoporosisFabiana Furci, Marco Umberto Scaramozzino, Giuseppe Rocco Talesa, et al.
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Vaccines|March 30, 2023
Special Issue on 'Asthma and Allergic Inflammation'Corrado Pelaia
ERJ Open Research|September 25, 2024
Interleukin 33: a suitable target for biological therapies of COPD?Corrado Pelaia
Medicina (Kaunas, Lithuania)|May 4, 2026
Chronic Respiratory Diseases: The Stories You Don't Want to MissMarcin Kurowski, Laura Malinauskienė, Corrado Pelaia
American Journal of Respiratory and Critical Care Medicine|December 8, 2023
Do Comorbidities Influence the Response to Biologics in Severe Asthma?Corrado Pelaia, Girolamo Pelaia, William Busse
Expert Opinion on Pharmacotherapy|April 8, 2017
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapyCarolina Vitale, Angelantonio Maglio, Corrado Pelaia, et al.
Respiratory Medicine|July 9, 2022
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicVincenzo Patella, Corrado Pelaia, Roberta Zunno, et al.
Drug Design, Development and Therapy|April 3, 2018
Benralizumab in the treatment of severe asthma: design, development and potential place in therapyCorrado Pelaia, Alessandro Vatrella, Andrea Bruni, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2023
Tezepelumab for asthmaSanti Nolasco, Corrado Pelaia, Giulia Scioscia, et al.
Expert Review of Respiratory Medicine|February 21, 2020
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectivesCorrado Pelaia, Alessandro Vatrella, Angela Sciacqua, et al.
Biomedicines|January 25, 2025
Connections and Unmet Needs: Severe Asthma Biologics and OsteoporosisFabiana Furci, Marco Umberto Scaramozzino, Giuseppe Rocco Talesa, et al.
Pageof 18